跳至主要内容
临床试验/NCT01280292
NCT01280292Unknown不适用

Central Hypothyroidism,a New Laboratory Approach for Hormone Measurement

Sheba Medical Center0 个研究点目标入组 50 人开始时间: 2011年2月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
50
主要终点
free T4 levels

研究概览

简要总结

Medical management of central hypothyroidism is controversial due to lack of reference for evaluation of pituitary negative feedback. Therefore, titration of medical treatment is based on T4 levels, measured with variable laboratory methods. Patients who have central hypothyroidism usually have concomitant deficiencies in other pituitary hormones for which they need replacement therapy such as steroids, testosterone and growth hormone. This combined hormone deficiency makes clinical and laboratory evaluation challenging among these patients. Symptomatically, central hypothyroidism is relatively mild and lack non-specific and it might be overlooked due to other hormonal deficiencies. Replacement therapy for central hypothyroidism is titrated by arbitrary target free T4 levels of above 50th percentile of normal. The goal of our study is to compare the standard results from well known measure methods to a new method for measuring Ft4 using Liquid chromatography - tandem mass spectrometry.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical evidence of central hypothyroidism: status post pituitary surgery and/or radiotherapy plus laboratory documentation of central hypothyroidism, with or without concurrent hormonal deficiencies in other axes, such as ACTH, LH, FSH

排除标准

  • Primary hypothyroidism

结局指标

主要结局

free T4 levels

时间窗: a year

次要结局

  • Symptoms of hypothyroidism(a year)

研究者

申办方类型
Other Gov

相似试验

Central Hypothyroidism, a Novel Laboratory... | 临床试验